Cheap, fast, one meal β the closest thing to a free home check on a part of your body you've never measured directly. The number you get isn't a diagnosis; it's a screen. Inside the typical range, you can stop wondering. Well outside it, you've found a real lever β fibre, fluid, activity β before anything more elaborate.
Food doesn't pour through you on a fixed timer. The stomach takes one to four hours to empty; the small intestine another three to five to pull out what it can; and then the colon takes anywhere from ten hours to three days deciding what to do with the leftovers. The colon is where the variation lives β it's storage tank, water-recycler, and fermentation room for your gut bacteria, all at once.
The longer something sits there, the drier it gets and the more your bacteria switch their menu. With fast transit and plenty of fibre, they make short-chain fats β acetate, propionate, butyrate β that the body uses. With slow transit and protein leftovers, they switch to making breakdown products β branched-chain fatty acids, p-cresol, indoles β that are not the ones you want.
The marker foods work because some food parts survive the trip intact. Sweetcorn kernels are wrapped in a cellulose skin your body can't break down; swallow one mostly whole and it lands in the toilet bowl looking exactly like the corn you ate. Beetroot does the same job by colour β turning stool and urine pink for about one person in five (the rest of us absorb the pigment without a visible trace). The blue dye used in modern research studies works on the same principle: something visible that doesn't get destroyed on the way through.
How to run it
Eat about half a cup of whole, lightly-cooked sweetcorn with a normal meal β swallow the kernels mostly whole, don't chew them down. The whole kernels are what you're going to recognise later. Note the time. Then, on every bowel movement after that, check the bowl. When you see the yellow kernels, note the time again. The hours between the two times are your transit estimate.
Run it on a normal day β not a feast, not a fast, not a travel day. Repeat on a different week before you trust the number.
Rough interpretation, healthy adults:
- Under 12 hours β very fast. See a doctor if it's persistent.
- 12 to 24 hours β fast end of normal.
- 24 to 48 hours β typical.
- 48 to 72 hours β slow end of normal.
- Over 72 hours β slow transit. Fibre, fluid, activity, retest.
Does the home test actually work
The clinical gold standard is the radio-opaque marker study β swallow a capsule of small plastic rings, get an X-ray five days later, count what's left in the colon. The home sweetcorn version was validated against that method in the 1970s, in a study that found single-stool analysis of a particulate marker tracked the full collection method closely (Cummings & Wiggins 1976). The modern equivalent is the wireless motility capsule, a swallowable sensor that records pressure, pH, and temperature continuously; it agrees with the X-ray methods within clinically useful bounds (Maqbool et al. 2009).
The cheap daily alternative is the Bristol Stool Form Scale β a seven-point picture chart from pellets (Type 1) to liquid (Type 7). Type 1 and 2 line up with slow transit; Type 6 and 7 with fast; Type 3 to 5 is the middle. The marker test is more precise, but Bristol catches most cases for free, every day (Lewis & Heaton 1997).
What most people get wrong
"Going daily means I'm fine." Healthy bowel frequency in adults runs from three times a day to three times a week. You can go every morning and still be carrying a four-day backlog β frequency and speed aren't the same measurement (Drossman & Hasler 2016, MΓΌller-Lissner et al. 2005).
"More fibre always speeds things up." Insoluble fibre β wheat bran is the cleanest example β does shorten transit in most people. Soluble, viscous fibre β psyllium, oat β works the other way: it normalises consistency, which can speed up slow transit and slow down fast transit. The two types do different jobs (McRorie & McKeown 2017).
"Toxins build up in the colon." The autointoxication story β that waste sitting in the gut poisons the bloodstream and needs to be cleansed out β was abandoned by mainstream medicine nearly a century ago. The real story is more interesting and more actionable: long transit shifts what your bacteria make from your food, not whether the food itself leaks poison through the gut wall (MΓΌller-Lissner et al. 2005, Roager et al. 2016).
Women, men, and the cycle
Women's transit is on average 30 to 50 percent longer than men's, at every age. In a clean radio-opaque marker study of healthy adults, men's median transit was around 30 hours; women's, around 47 (Degen & Phillips 1996). The ZOE blue-dye study found the same pattern in a much larger cohort (Asnicar et al. 2021). The numerical flags β under 12 hours, over 72 β still apply universally, but the in-between numbers land differently. A 36-hour result is on or near the median for a 30-year-old woman; the same number is on the slow end for a 30-year-old man.
Pregnancy slows transit further β progesterone relaxes the smooth muscle that does the work. That's normal physiology, not a malfunction.
Transit also lengthens with each adult decade, modestly, in both sexes. By the time someone's in their seventies the average is creeping into the 50- to 60-hour range β partly biology, partly less fluid and less walking, partly the medications most older adults end up on.
What happens if you ignore it
The typical slow-transit reader isn't the four-day case who already knows something is wrong β it's the every-morning, daily-defecation reader whose transit is quietly 72 hours and who's never thought to measure it. Day to day, the version that plays out is the dinner that doesn't quite settle, the bathroom visit that takes ten minutes of waiting and effort, the bloated-by-Wednesday feeling that's quietly become normal. People around you notice in small ways: you turn down the second helping more often, you eat lighter when you go out, you ask where the bathroom is when you arrive somewhere new. And when transit runs really slow, bacteria get the time to creep up into the small intestine where they don't belong β one of the routes into the bloating and gas of SIBO.
The years compound it. The fermentation profile your bacteria switch to when stool sits longer β branched-chain fatty acids, p-cresol, indoles β is the one observational studies link to higher colorectal cancer risk and a steadier background level of gut inflammation (Roager et al. 2016). Burkitt's old comparison of rural African populations (around 30-hour transit, almost no diverticular disease) with industrialised Western populations (around 80-hour transit, a lot of it) is messy as direct causal evidence, but the same direction has shown up under every modern lens that's been pointed at it (Burkitt et al. 1972).
Rapid transit (under 12 hours, persistent) is louder. You learn the bathroom locations of every restaurant. You start carrying spare clothes. The cost compounds in nutrients lost, electrolytes off, and an underlying cause β bile-acid issues, untreated coeliac, microscopic colitis β that keeps doing its work unchecked. The point of measuring is to catch the pattern early enough to do something about it.
Why the test goes wrong
You chewed the corn. The skin is what makes the kernel recognisable later. Chew through it and you've eaten corn for dinner with no test running. Swallow whole β it feels unnatural, but that's the method.
You checked once a day. Eat corn at 7 PM Tuesday, check Wednesday morning only, see kernels, record 14 hours β wrong, it could have been any time between 10 PM Tuesday and 8 AM Wednesday. Check every visit until you see kernels, then note the time.
You treated one result as the answer. A single test on a feast day is a noisy estimate. Repeat on a different week before changing anything in your diet. And resist diagnosing yourself β a chronic constipation diagnosis under the Rome IV criteria requires a months-long pattern of specific symptoms, not one slow result (Drossman & Hasler 2016).
When the test is the wrong tool
Eating sweetcorn is eating sweetcorn β there's nothing to worry about in the test itself. But the test answers a body-literacy question, not a clinical one. Bleeding from the rectum, unexplained weight loss, new bowel changes after age 50 with no recent screening, persistent night-time symptoms, a family history of colorectal cancer, iron-deficiency anaemia of unclear cause β any of those is a reason to see a clinician first. Transit time is downstream of the things that matter in those situations; the diagnosis sits upstream (Drossman & Hasler 2016).
What you get if you act on it
Within a week of acting on a slow result β 5 to 15 grams of insoluble fibre a day, more water, more walking β most people feel the difference. Stools soften. The evening bloat fades. The bathroom visit takes less effort. Retest at two weeks: a 78-hour transit will often come down to 40-something (McRorie & McKeown 2017, Burkitt et al. 1972).
For rapid transit, the action is opposite β soluble, viscous fibre (psyllium, 5 to 10 grams a day), back off sugar alcohols and excess raw bran, see a clinician if it persists past a fibre trial. The felt change is steadier digestion, less urgency, fewer cancelled mornings (McRorie & McKeown 2017).
Over years, the version of you who measured and acted has a different bacterial fermentation pattern β more short-chain fats, fewer of the protein-breakdown products β and a different long-term risk profile for the colon-related disease cluster (diverticular disease, haemorrhoids, possibly colorectal cancer). None of those shift dramatically week to week; they're slow background changes. But they're real, and the test was what told you to start (Roager et al. 2016, Burkitt et al. 1972).
Related
- Dietary fibre intake β the primary lever for slow transit
- Psyllium and soluble fibre supplementation
- The Bristol Stool Form Scale as a daily tracking tool
- The gut microbiome and what feeds it
- Chronic constipation under the Rome IV criteria
- The wireless motility capsule for clinical evaluation when home testing flags something worth investigating
- β If your transit is off, fiber is the first lever β and the type matters more than the amount.
- β Slow transit usually means too little fibre or fluid β water is half of what keeps things moving at a healthy pace.
- β Very slow transit lets bacteria migrate into the small bowel β one route to the bloating and gas of SIBO.
- β Transit time and stool form are two cheap windows on the same plumbing.
- β A slow result on the corn test can be the first sign of the constipation this covers fixing.
- β A very fast corn test isn't just 'good digestion' β when it's loose and frequent too, it can be the diarrhea that deserves a real workup.
- β Sluggish transit improves when the gut's between-meal cleaning cycle gets to finish β which is exactly what spacing meals four hours apart restores.
- β Psyllium is a simple way to nudge a transit time that's running too fast or too slow.
Substance + claimed effects
Whole-gut transit time (WGTT) is the interval between food ingestion and excretion of the indigestible residue of that meal. Measured at home using a visible marker food β most commonly sweetcorn (intact yellow pericarp kernels resistant to colonic fermentation) or beetroot (betalain pigment colouring stool and urine pink to red) β it gives a single-point estimate of how long the digestive tract took to process one meal. The entry covers the at-home marker-food test on a one-off or periodic basis: how to perform it, what the result means, how it informs fibre and hydration decisions, when it suggests constipation (transit >72 h per the classical threshold) or rapid transit (<12β14 h), and where it sits relative to the clinical gold standards (radio-opaque marker studies, wireless motility capsule). The claimed consequences span gut-health monitoring, fibre-intake calibration, detection of asymptomatic constipation, and basic body literacy β none transformative on their own, but cheap, repeatable information about a system most people never measure.
Evidence by addressing question
mechanism
WGTT is the sum of three regional transit times: gastric emptying (typically 1β4 h depending on meal composition), small-bowel transit (3β5 h), and β by far the largest and most variable component β colonic transit (10β60+ h) Maqbool et al. 2009, Degen & Phillips 1996. The colon is where stool is dehydrated, fermented, and stored; the longer it sits there, the more water is reabsorbed and the more proteolytic fermentation predominates over saccharolytic fermentation, producing branched-chain fatty acids, phenols, p-cresol and indoles rather than the short-chain fatty acids (acetate, propionate, butyrate) of rapid carbohydrate fermentation Roager et al. 2016.
Marker foods exploit the digestive tract's inability to break down specific food components. Sweetcorn kernels are jacketed in a pericarp built from cellulose and hemicellulose that human enzymes cannot cleave; if not chewed, the whole kernel passes intact and remains visually identifiable in stool. Beetroot delivers betalain pigments (betacyanin, betaxanthin) that resist degradation in roughly 10β20% of people (a genetic polymorphism affecting gut absorption and stomach acidity), producing visible beeturia in urine and red-to-pink colouration of stool Cummings & Wiggins 1976. A blue-dye muffin marker developed for the PREDICT cohort produces nearly universal visible blue stool because the dye load is large and not pH-dependent Asnicar et al. 2021. The same principle underpins the clinical radio-opaque marker test (Sitzmark / Hinton method): swallow a capsule of plastic rings, image the abdomen 5 days later, count what remains in the colon.
evidence
The sweetcorn marker has been used in epidemiology and physiology since the 1970s and was validated against carmine dye and radio-opaque markers by Cummings and Wiggins, who showed that single-stool analysis using a particulate marker correlated tightly (r β 0.85) with the more burdensome whole-stool collection method Cummings & Wiggins 1976. The wireless motility capsule (SmartPill) β the modern clinical reference β measures pH, pressure, and temperature continuously and agrees with scintigraphy and radio-opaque markers within clinically acceptable bounds for whole-gut transit Maqbool et al. 2009.
The largest direct test of the marker-food approach is the ZOE PREDICT 1 sub-study: 863 healthy adults swallowed a blue-dye muffin and self-reported the appearance time of blue stool. Median transit time was 28.7 h; the interquartile range stretched from 17 to 42 h; values <14 h or >58 h fell outside the central healthy band. Transit time correlated with gut microbiome composition (Ξ²-diversity), postprandial triglyceride and glucose responses, and visceral fat β independent of age, sex, and BMI. The blue-dye method also outperformed self-reported stool frequency and Bristol stool form for identifying microbiome-defined metabolic phenotypes Asnicar et al. 2021. Lewis and Heaton had earlier established that stool form on the 7-point Bristol scale correlates inversely with transit time (Type 1 pellets β slow transit, Type 6β7 loose stool β rapid transit; r > 0.7 in healthy adults), making Bristol a useful cheap proxy when marker-food testing is impractical Lewis & Heaton 1997. Roager et al. demonstrated in 98 healthy adults that colonic transit time (radio-opaque markers) correlated with bacterial protein fermentation markers and mucosal turnover β long transit was associated with a metabolite profile previously linked to colorectal cancer risk Roager et al. 2016. Burkitt's classical observational work (rural African vs. British populations) found mean transit times of ~33 h vs. ~80 h, with stool weights of ~470 g vs. ~110 g β the foundational data underpinning the fibre hypothesis for diverticular and colorectal disease Burkitt, Walker & Painter 1972.
Limitations of the single-marker home test are well-characterised: a single measurement captures one meal's transit, not the patient's typical transit; meal composition (fat, fibre, calorie load) influences gastric emptying and may shift the result by several hours; menstrual cycle phase shifts transit by 10β20% Degen & Phillips 1996; physical activity, stress, sleep deprivation, and travel all perturb it acutely. Test-retest reliability for radio-opaque markers across multiple measurements is moderate (intraclass correlation ~0.6β0.7); for single marker-food tests it is lower. The accepted use case is screening β identifying outliers from a population distribution β rather than precise quantification.
protocol
The standard sweetcorn protocol: eat a measured serving (roughly half a cup, 100β150 g) of whole, lightly-cooked corn kernels with a normal meal, swallowed without thorough chewing β chewing destroys the pericarp envelope that makes kernels recognisable. Note the meal time. Watch each subsequent bowel movement until intact yellow kernels appear, then note the time again. The elapsed interval is the WGTT estimate.
The beetroot variant uses 1β2 medium roasted or boiled beets; the marker is the pink-red colouration of stool (and urine, beeturia). Beetroot is less reliable as a stool marker because the colour response is bimodal across the population β some people excrete betalain pigments in stool and urine, some do not, depending on stomach acidity, oxalate content of the meal, and host genetics. Sweetcorn is the more robust default; beetroot is useful as a back-up or for people who don't tolerate corn.
The blue-dye muffin protocol (per Asnicar et al.) standardises a 5 g dose of blue food dye in a controlled muffin matrix and is the cleanest research method; commercial kits adapted from this design exist. For home use without a kit, sweetcorn is functionally equivalent for the same purpose: screening for transit outside the 14β58 h band.
Interpretation thresholds (rough, healthy-adult ranges): <12 h is very rapid (suggests malabsorption, IBS-D, hyperthyroidism, infection, or laxative use); 12β24 h is rapid; 24β48 h is typical; 48β72 h is the slow end of normal; >72 h meets the classical slow-transit threshold and warrants attention if persistent. Persistent outliers in either direction β confirmed by repeating the test on a different week β are the signal worth acting on.
contraindications
There are no medical contraindications to eating sweetcorn or beetroot in normal food quantities outside of allergy. Marker-food testing is inappropriate as a substitute for clinical evaluation in the presence of red-flag symptoms: rectal bleeding, unintended weight loss, family history of colorectal cancer with no recent screening, persistent vomiting, severe abdominal pain, new-onset constipation or diarrhoea in adults over 50, iron-deficiency anaemia, nocturnal symptoms. These are alarm features that warrant a clinician's evaluation regardless of transit time Drossman & Hasler 2016. The test is also of limited diagnostic value during active gastroenteritis, after recent antibiotic courses, during opioid analgesic use, or in the immediate post-operative period β transit is acutely shifted by all four and home measurement will reflect the acute state rather than the steady state.
misconceptions
The most durable myth is that "regular" bowel movements mean daily ones. Healthy bowel frequency in adults spans roughly 3 per day to 3 per week; daily defecation is the mode but not the medical threshold Drossman & Hasler 2016, MΓΌller-Lissner et al. 2005. A second common error is conflating frequency with transit time β someone defecating daily can still have a 72+ hour transit if they're processing several meals' worth of residue at once; conversely, a person going every third day can have normal transit if intake is modest. Bristol stool form is a better proxy than frequency for transit, but the marker-food test directly resolves the ambiguity Lewis & Heaton 1997. A third misconception, propagated by colon-cleanse and detox marketing, is that long transit causes "autointoxication" via toxin reabsorption β the autointoxication hypothesis was abandoned in mainstream medicine by the mid-20th century and lacks mechanistic support, though the related modern claim that long transit shifts microbial metabolism toward less favourable end-products has actual data behind it Roager et al. 2016, MΓΌller-Lissner et al. 2005. A fourth: that more fibre always speeds transit. Insoluble fibre (wheat bran) does shorten transit in most people; soluble viscous fibre (psyllium, oat Ξ²-glucan) primarily normalises stool consistency and can slow rapid transit while speeding slow transit McRorie & McKeown 2017.
audience
Sex differences are large and reproducible. Women's whole-gut transit is on average 30β50% longer than men's β Degen and Phillips found median WGTT of ~30 h in men vs. ~47 h in women using radio-opaque markers, with the difference concentrated in the colon and unrelated to dietary fibre intake Degen & Phillips 1996. Asnicar et al. found the same pattern with the blue-dye marker: women's median transit was significantly longer than men's Asnicar et al. 2021. Pregnancy slows transit further (progesterone-mediated smooth-muscle relaxation), and transit lengthens with each decade of adult life, modestly. Implication: a 36-hour result in a 30-year-old woman is on or near the population median; the same result in a 30-year-old man sits slightly above. The thresholds (12 h, 72 h) are still useful but interpretation gains nuance with the sex baseline.
Athletes and people on high-fibre, high-volume diets often run faster transit (24β30 h) regardless of sex. Sedentary adults, elderly adults, people on opioids or anticholinergics, and people with hypothyroidism trend slower.
alternatives
Bristol Stool Form Scale: a 7-point visual scale (Type 1 hard pellets through Type 7 watery) is cheaper still, requires no marker meal, and correlates well with transit (Type 1β2 β slow, Type 3β5 β normal, Type 6β7 β rapid) Lewis & Heaton 1997. The trade-off: Bristol gives a coarser bin and depends on a habitual stool, whereas the marker food gives a continuous number for one specific meal. For ongoing tracking, Bristol is the lighter-touch option; for a periodic calibration, marker food is more informative.
Stool frequency tracking: simplest but lowest-resolution; misses transit changes when frequency is constant. Useful as a complement, not a replacement.
Clinical options if home testing flags a problem: radio-opaque marker study (Sitzmark, performed in a clinic; multiple capsules and abdominal X-ray on day 5); wireless motility capsule (SmartPill, regional and whole-gut transit, FDA-cleared, not always insurance-covered); scintigraphy (regional transit, mostly research). These are reserved for evaluation of suspected slow-transit constipation, gastroparesis, or chronic intestinal pseudo-obstruction Maqbool et al. 2009.
failure-modes
Most home-test failures fall into a small set. Chewing the corn destroys the pericarp envelope and erases the marker β the kernels need to be swallowed largely intact, which feels unnatural and is the single biggest user error. The beetroot variant fails for the subgroup who don't excrete visible betalain; a missed colour signal can be misread as very long transit when in fact the marker simply isn't visible. Eating marker food on a day with an unusual meal pattern (large fatty meal, prolonged fast, alcohol) shifts the result by hours and produces a noisy estimate; a controlled day with normal food beats a feast day. Missing the first appearance β only checking once per day β biases the estimate upward by 12 to 24 h. Treating a single result as definitive, rather than repeating on a different week, is the misuse most likely to lead to over-action on diet.
A subtler failure is interpretive: extrapolating from a single fast transit to "I have IBS-D" or from a single slow transit to "I'm constipated". The Rome IV diagnostic criteria require symptom-pattern duration (weeks to months) and specific clinical features beyond transit alone Drossman & Hasler 2016.
stakes
Chronic outlier transit, persistent across measurements, is not benign. Persistently slow transit (>72 h) is associated with the metabolite profile Roager et al. mapped: elevated p-cresol, indoxyl-sulphate, branched-chain fatty acids β markers of proteolytic colonic fermentation that observational data tie to colorectal cancer risk, kidney disease in advanced CKD, and possibly cardiovascular endpoints Roager et al. 2016. The classical Burkitt observation that low-transit-time populations had near-absent diverticular disease, colorectal cancer, and haemorrhoids is observational and ecologically confounded, but the mechanistic thread (stool weight, transit, fermentation profile) has held up Burkitt et al. 1972. Rapid transit (<12 h, persistent) signals possible malabsorption β bile-acid diarrhoea, microscopic colitis, untreated coeliac, hyperthyroidism β and is a reason to escalate to a clinician rather than self-treat. The day-to-day toll of either extreme is real: long transit produces bloating, hard stools, straining (haemorrhoid and fissure risk), and the felt sense of "always full"; rapid transit produces urgency, electrolyte and nutrient loss over time, and quality-of-life impairment in line with mildβmoderate IBS-D.
payoff
The actionable upside of a single transit measurement is information, not direct biological effect. Knowing that your transit sits at 36 h with a Type 4 stool is reassurance β fibre and hydration are adequate, no further action required. Knowing transit is 80 h with Type 1β2 pellets is an explicit prompt to act: add 5β15 g of insoluble fibre per day for 2β4 weeks (wheat bran is the most-studied), increase fluid intake to ~30 ml/kg, increase physical activity, and retest McRorie & McKeown 2017, Burkitt et al. 1972. For the rapid-transit case, the action is opposite β soluble viscous fibre (psyllium 5β10 g/day), reduce sugar alcohols and excess insoluble fibre, evaluate for bile-acid malabsorption if persistent McRorie & McKeown 2017. Felt benefits of normalising a previously outlier transit appear over 2β4 weeks of intervention: fewer bloating episodes, easier stools, less straining, less urgency. The longevity case (lower colorectal cancer risk, lower diverticulitis risk, better microbiome end-products) accrues over decades and rides on the Burkitt / Roager evidence β real but slow.
out-of-scope
Adjacent topics: dietary fibre intake (the primary intervention lever for slow transit); psyllium supplementation; the microbiome and short-chain fatty acid production; chronic constipation diagnosis and treatment (Rome IV); IBS subtypes; Bristol Stool Form as a stand-alone tracking tool; the wireless motility capsule clinical pathway.
The credibility range
Optimist case
WGTT is a clinically meaningful number with a 50-year evidence base. The marker-food method is cheap, validated against radio-opaque markers (Cummings & Wiggins 1976), and operationalised at scale by the largest at-home transit study to date (ZOE PREDICT 1, Asnicar 2021) in 863 adults, where transit predicted microbiome composition, metabolic responses, and visceral adiposity independent of standard confounders. Transit time is upstream of microbial fermentation profile (Roager 2016) which is mechanistically linked to colon-cancer risk markers and inflammation. The home test surfaces a hidden variable: many adults with slow transit don't recognise the problem because frequency seems normal and Bristol stool form changes slowly. A single sweetcorn meal yields an estimate that is "good enough" for the binary screening question (am I inside the 14β58 h band?), at zero cost, with no equipment. For a body literacy intervention β cheap, fast, repeatable, mechanistically grounded β this clears the bar comfortably.
Skeptic case
A single-meal transit measurement is noisy. Within-person test-retest variability is large; meal composition, menstrual cycle phase, stress, travel, and sleep all shift it by hours. The 14β58 h band from Asnicar 2021 is a healthy-cohort distribution, not a clinical threshold β selecting individuals who fall outside it on a single test will over-identify normal variation as pathology. Bowel frequency and Bristol stool form already give most of the information; layering a marker-food test adds resolution but rarely changes the action plan. Most causes of slow transit (low fibre, low fluid, low activity, opioids) and rapid transit (lactose intolerance, FODMAP sensitivity, anxiety) are identifiable by symptom history and dietary recall without a transit number. The clinical thresholds (<12 h, >72 h) were derived in heterogeneous samples and are sex-blind, despite a 30β50% sex difference. A real diagnosis of slow-transit constipation requires a multi-day radio-opaque marker study with serial imaging, not a single sweetcorn meal. Over-reliance on the home test risks both false positives (anxiety, restrictive eating) and false negatives (a normal one-meal result in someone with episodic slow-transit constipation).
Author's call
The marker-food test is a body-literacy tool of real but modest value. It is not a clinical diagnostic, and it is not a continuous monitoring system. Used as intended β a periodic single-point check that flags outliers worth investigating with a clinician or addressing with first-line fibre/fluid/activity adjustments β it is cheap, harmless, and produces information that simple frequency and Bristol observation underweight. The strongest case is in the underdiagnosed slow-transit-but-daily-defecation phenotype: people whose frequency looks normal but whose transit is genuinely >72 h, who would benefit from fibre and activity changes. The weakest case is the worried-well over-interpreter who runs the test repeatedly and chases noise. Evidence score 4 (validated method, large cohort, multi-decade history) rather than 5 (no Cochrane-level systematic review of home transit testing as an intervention exists); controversy 1 (universal consensus on the underlying measurement; minor disagreement on the threshold values and the clinical utility of a single home measurement).
Stakeholder + incentive map
- Commercial β at-home microbiome and gut-health testing companies (ZOE, Viome, Atlas Biomed) promote transit-time testing as a complementary measurement; some sell branded blue-dye kits. Their commercial interest is downstream β selling the microbiome test, the personalised programme, the food brand. Transit-time messaging is honest in the literature they cite but the framing leans into the high end of the claims.
- Clinical / professional β gastroenterologists view the home test as a reasonable patient-led screening but rely on radio-opaque markers or wireless motility capsule for diagnosis. The Rome Foundation and AGA practice updates treat WGTT as one piece of a broader functional GI evaluation. There is no clinical guideline specifically endorsing home marker-food testing β it sits in the patient-education space.
- Community / lay β body-literacy and quantified-self communities have used the sweetcorn test for decades; nutrition and gut-health writers (Tim Spector, ZOE editorial, Monash FODMAP team) have popularised it. Reddit r/ibs and r/constipation feature thousands of posts where the test is recommended as a self-diagnostic step.
- Counter-incentive β colon-cleanse and detox industries push narratives ("toxins in your colon", "you have pounds of impacted stool") that the marker-food test would deflate; the test exposes their claims as exaggerated. Conventional medicine pushes back against over-medicalisation of normal bowel variation.
Population variability
- Sex. Women's transit is 30β50% longer than men's at every age band Degen & Phillips 1996, Asnicar et al. 2021. Population thresholds should be sex-aware in practice; in this entry, we present the unified threshold but flag the sex pattern.
- Cycle phase. Luteal-phase transit is faster than follicular in some studies; pregnancy slows transit substantially via progesterone effects on smooth muscle Degen & Phillips 1996.
- Age. Transit slows modestly with each adult decade; elderly transit times of 60β80+ h are common and reflect reduced colonic motility, reduced fluid intake, reduced activity, and frequent polypharmacy (especially anticholinergics, opioids, calcium channel blockers).
- Diet. Habitual fibre intake (g/day) inversely correlates with transit; populations with traditional high-fibre diets average 24β36 h vs. 60β80+ h in low-fibre Western samples Burkitt et al. 1972.
- Activity. Sedentary lifestyle slows transit; regular aerobic exercise shortens transit by a measurable amount in interventional studies.
- Medications. Opioids, anticholinergics, iron supplements, calcium-channel blockers, ondansetron all slow transit. Magnesium-containing antacids, metformin, SSRIs (some), and laxatives all speed it.
- Comorbidities. Hypothyroidism, diabetes (autonomic neuropathy), Parkinson's, scleroderma, chronic kidney disease β all shift transit, usually slower. Hyperthyroidism, untreated coeliac disease, IBD flares β faster.
Knowledge gaps
- No randomised trial has tested whether at-home marker-food screening, followed by fibre/fluid/activity intervention for outliers, improves long-term health endpoints beyond what symptom-based screening achieves. The chain of inference (test β identify outlier β intervene β improved outcome) is reasonable but unproven as a stack.
- The 14β58 h "healthy range" from Asnicar 2021 reflects a UK/US, mostly-Caucasian, predominantly-female cohort. Cross-population validity (East Asian, South Asian, Sub-Saharan African dietary contexts) is incomplete.
- Test-retest reliability of single marker-food measurements has not been formally quantified at scale; estimates from radio-opaque marker work (ICC ~0.6β0.7) probably overstate single-marker-food reliability.
- The relationship between transit time and microbiome metabolite profile (Roager 2016) is correlational and possibly bidirectional β microbial composition may shape transit just as transit shapes composition.
- Whether intentionally normalising transit (from 80 h down to 36 h via fibre/fluid intervention) reduces colorectal cancer incidence over decades has not been tested directly; the inference is observational and ecological.
Scope. Covers all four consequences named in the brief β understanding digestion (mechanism), identifying constipation or rapid transit (interpretation thresholds in protocol + stakes), fibre-intake decisions (payoff + misconceptions on soluble vs. insoluble), and gut-health monitoring (audience + the repeat-on-a-different-week protocol note). No narrowing.
Scoring calls.
- health_short_term: 1, not 0 or 2. The substance is measurement; it doesn't directly change physiology. But information that surfaces a real lever (slow transit β fibre/fluid/activity) earns more than a 0 holistically β the chain test β action β felt improvement is short and well-evidenced. Held at 1 rather than 2 because most testers will land in the typical band and gain reassurance, not improvement; the felt lift is concentrated in the outlier subset.
- longevity: 0, deliberately. Considered scoring 1 on the same chain-of-inference logic (slow transit β fibre intervention β lower colorectal cancer risk via Roager/Burkitt). Decided against: the longevity score belongs to the fibre-intake / colorectal-screening entries that own the actual intervention. Scoring it here would double-count.
- evidence: 4, not 5. The measurement itself has strong validation (Cummings & Wiggins 1976, Maqbool 2009, Asnicar 2021, Lewis & Heaton 1997). What's missing for a 5 is a Cochrane-level systematic review of home transit testing as an intervention stack β i.e. screening + intervention β outcome. The chain is reasonable, individually evidenced, but unproven as a stack.
- cadence: as-needed, not yearly. A periodic check rather than a calendar item β most readers will run it once out of curiosity, again if something changes (new diet, new medication, persistent symptom), and rarely after that. Calling it yearly would manufacture a habit it doesn't earn.
Future-link candidates. Dietary fibre intake (the primary downstream action lever, especially insoluble vs. soluble); psyllium specifically; Bristol Stool Form Scale as a daily tracking tool (would warrant its own short entry); chronic constipation under Rome IV; the gut microbiome and what feeds it; the wireless motility capsule clinical pathway.
Separate-entry candidates. Bristol Stool Form Scale β mentioned here as an alternative but warrants its own entry as a daily-tracking tool with different cadence and audience. Chronic constipation diagnosis β clinical entity, different audience, needs its own treatment-focused entry. Wireless motility capsule β clinical-only, decide-action.
Stakeholder context. ZOE commercialises a blue-muffin transit kit derived from the Asnicar 2021 study; we cite the underlying paper but don't endorse any kit. Sweetcorn is the free equivalent for the screening use case, and the entry recommends it on those grounds.
Hard call. Whether to lead the dek with the sweetcorn instruction or with the punchline about frequency-vs-transit. Chose sweetcorn first β concrete, visual, memorable; the frequency-vs-transit insight lands harder when it follows the lived image. Considered an alternative dek opening on the daily-doesn't-mean-fast misconception; rejected as too talking-head for the casual reader.
Gut Transit Time
One serving of corn at dinner, then check the toilet bowl until the yellow kernels show up. That's it.
The sweetcorn marker was validated against clinical methods in the 1970s; the modern blue-dye version was tested in 863 adults in 2021.
Catches a slow or fast gut early enough to fix it with food, water, and walking β before it becomes a daily-comfort problem.